Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03128658 · ClinicalTrials.gov registry record
Trauma Induced Coagulopathy and Inflammation
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 300
- Enrollment target
NCT03128658: Completed study, sponsored by University of Pennsylvania.
NCT03128658 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03128658 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
While a number of factors are known to be associated with the development of trauma induced coagulopathy (TIC), inflammation, and multi-organ failure, we currently cannot predict which patients are at risk for developing these life threatening conditions with any certainty. In this prospective observational study, we will investigate the many factors that contribute to the development of trauma induced coagulopathy, post injury inflammation and the development of organ dysfunction in order to develop a multi scale computational algorithm of clinical prediction. Using a convenience sample technique, demographic data, physiologic data, blood samples and clinical variables will be collected over 5 days following traumatic injury. A computational model will be used to predict the development of TIC and multi-organ failure.
Primary Outcome
Variables: Reaction time (R value), the K value, the angle and the maximum amplitude (MA)
Interventions
- DIAGNOSTIC_TEST Thromboelastography
- DIAGNOSTIC_TEST Computational model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2020-12-31 |
What the finished NCT03128658 record still lists
NCT03128658 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Thromboelastography is the first listed.
NCT03128658 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03128658 about?
NCT03128658 is a clinical study titled "Trauma Induced Coagulopathy and Inflammation". While a number of factors are known to be associated with the development of trauma induced coagulopathy (TIC), inflammation, and multi-organ failure, we currently cannot predict which patients are at risk for developing these life threatening conditions with any certainty. In this prospective obser...
What is the current status of trial NCT03128658?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2017-02-27. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03128658?
The interventions under investigation include: Thromboelastography (DIAGNOSTIC_TEST), Computational model (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03128658?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI